Ion Beam Applications (IBA), the specialist Belgian healthcare
equipment manufacturer, has launched a new leasing solution for its
proton therapy centres.
MaxiPRO is an all-inclusive finance offering which will cover
IBA’s flagship Proteus proton therapy system, its installation,
ancillary systems, and the operation and maintenance of the
equipment.
Go deeper with GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
“Until now, the complexity of financing a proton therapy centre,
and the delay between capital expenditures and revenue generation
were major impediments for our customers that wanted to make proton
therapy accessible for their patients,” said Jean Marc Andral,
president of IBA’s proton therapy business.
Proton therapy is an advanced alternative to x-ray radiation
therapy for certain types of cancerous and non-cancerous tumors,
the company said.
“My hope is that MaxiPRO will accelerate access to proton
therapy technology and hence make this highly precise cancer
treatment available for more and more patients in the near future,”
added Pierre Mottet, chief executive officer of IBA.
Jason T Hesse
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
